Hope Biosciences Reports Positive Published Clinical Data Following Stem Cell Therapy in Chronic Traumatic Brain Injury
HOUSTON--(BUSINESS WIRE)-- #biopharma--For millions of people living with the long-term effects of traumatic brain injury (TBI), the prevailing belief has been that chronic neuroinflammation causes recovery to plateau over time, meaning correspondingly few long-range care options. New research published in the prestigious journal Brain, one of the world's leading neurology journals, is challenging that assumption. “Our findings suggest that chronic neuroinflammation may be a treatable target, even years aft.